Lupin Limited has informed the Exchange regarding a press release dated February 17, 2023, titled "Lupin Receives EIR from U.S. FDA for its Injectable Facility in Nagpur.".
Press Release Feb 17 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Feb 14 2023
- Press Release Feb 09 2023
- Press Release Feb 03 2023
- Press Release Jan 31 2023
- Press Release Jan 24 2023
Later from Lupin
- Press Release Feb 21 2023
- Press Release Mar 01 2023
- Press Release Mar 10 2023
- Press Release Mar 13 2023
- Press Release Mar 17 2023
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin